NSEOutcome of Board Meeting4d ago · 5 Nov 2026, 08:34 pm

Outcome of Board Meeting

Vaishali Pharma Limited · VAISHALI

✦ AI SummaryMgmt Change

Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026, where the Board considered and approved the appointment of two new independent directors, Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah, and decided to defer the proposal for issuance of equity shares by way of preferential issue for further evaluation and consideration.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026.

Attachments (1)

📄

VAISHALI_05112026203413_OutcomeVPL.pdf

pdf

Download →
View document text
Date: 05th November, 2026 National Stock Exchange of India Ltd., Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051. Stock Code: VAISHALI Sub: Outcome of Board Meeting held on Thursday, 05th November, 2026 Dear Sir/Madam, In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("the Listing Regulations"), we wish to inform you that, in their meeting held today i.e. 05th November, 2026 has inter-alia considered and approved the following: 1. Appointment of Mr. Rohil Sanjay Desai (DIN: 12030412) as an Additional Director of the Company under Independent Category with effect from Thursday, 05th November, 2026, subject to approval of Members; Accordingly, the details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 is attached herewith as “Annexure I”. 2. Appointment of Mr. Ketur Kishor Shah (DIN: 11956456) as an Additional Director of the Company under Independent Category with effect from Thursday, 05th November, 2026, subject to approval of Members; Accordingly, the details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 is attached herewith as “Annexure I”. 3. The Board, inter alia, considered the proposal for issuance of equity shares of the Company by way of preferential issue in accordance with the applicable provisions of the Companies Act, 2013, the SEBI Listing Regulations, the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws. After due deliberations, the Board decided to defer the proposal for issuance of equity shares by way of preferential issue for further evaluation and consideration. Accordingly, no decision was taken by the Board in respect of the said proposal at the meeting. The Company shall make the necessary disclosures to the Stock Exchange(s) in accordance with the applicable provisions of the SEBI Listing Regulations as and when the matter is considered and approved by the Board. The meeting of the Board commenced at 07:00 P.M. and concluded at 08:15 P.M. Kindly take the above on record. Thanking You, Yours Faithfully, For Vaishali Pharma Limited Vishwa Mekhia Company Secretary Cum Compliance Officer Annexure-I Details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026: Sr. Particulars Details Details 1. Name & DIN Mr. Rohil Sanjay Desai Mr. Ketur Kishor Shah (DIN: 12030412) (DIN: 11956456) 2. Reason for Change viz. Appointment of Mr. Rohil Appointment of Mr. Ketur appointment, re- Sanjay Desai as an Kishor Shah as an Additional appointment, resignation, Additional Director on the Director on the Board of the removal, death or Board of the Company Company designated as a otherwise designated as a Non- Non-Executive Independent Executive Independent Director Director 3. Date of appointment and November 5, 2026 November 5, 2026 term of appointment Term of Appointment Term of Appointment The term of his appointment The term of his appointment as an Independent Director as an Independent Director shall be for a period of five shall be for a period of five (5) years, not liable to retire (5) years, not liable to retire by rotation, subject to the by rotation, subject to the approval of shareholders, as approval of shareholders, as per regulatory requirements. per regulatory requirements. 4. Brief Profile (in case of Mr. Rohil Desai is a chef, Mr. Ketur Shah is a finance Appointment) hospitality entrepreneur, professional with and food content creator qualifications in CA and with a background in CFA, and over 15 years of Pharmacy and formal experience in the financial training in Culinary Arts services industry. Currently from the Academy of Pastry serving as the Head – and Culinary Arts, Mumbai. Investment Banking at Abans He is the founder of APRIL Financial Services, Mr. Ketur Studio / APRIL Hospitality, Shah brings extensive an artisanal Italian-inspired expertise in investment gelateria and café, where he banking, capital markets, and leads culinary operations, corporate finance. gelato production, menu development, and brand experiences. With experience in culinary R&D, kitchen management, food styling, content creation, and private catering, Rohil brings together culinary creativity, entrepreneurial vision, and a passion for hospitality. 5. Disclosure of He is not related to any He is not related to any relationships between Director of the Company Director of the Company and directors (in case of and satisfies the criteria of satisfies the criteria of appointment of a independence prescribed independence prescribed Director) under the Companies Act, under the Companies Act, 2013, and SEBI Listing 2013, and SEBI Listing Regulations. Regulations. 6. Information as required He is not debarred from He is not debarred from pursuant to BSE Circular holding the office of Director holding the office of Director with ref. No. by virtue of any SEBI order by virtue of any SEBI order LIST/COMP/14/2018- or any other such authority. or any other such authority. 19 and the National Stock Exchange of India with ref. No. NSE/CML/2018/24, dated 20th June 2018